PRIMACOR Drug Patent Profile

✉ Email this page to a colleague

When do Primacor patents expire, and when can generic versions of Primacor launch?

Primacor is a drug marketed by Sanofi Aventis Us and is included in two NDAs.

The generic ingredient in PRIMACOR is milrinone lactate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Primacor

A generic version of PRIMACOR was approved as milrinone lactate by FRESENIUS KABI USA on May 28^th, 2002.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for PRIMACOR?
What are the global sales for PRIMACOR?
What is Average Wholesale Price for PRIMACOR?

Summary for PRIMACOR

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	131
Clinical Trials:	11
Patent Applications:	3,885
DailyMed Link:	PRIMACOR at DailyMed

Drug patent expirations by year for PRIMACOR

Recent Clinical Trials for PRIMACOR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Mahidol University	Phase 2
Zagazig University	Phase 4
Lipscomb University	Phase 1

See all PRIMACOR clinical trials

US Patents and Regulatory Information for PRIMACOR

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sanofi Aventis Us	PRIMACOR	milrinone lactate	INJECTABLE;INJECTION	019436-001	Dec 31, 1987		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sanofi Aventis Us	PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	020343-003	Aug 9, 1994		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sanofi Aventis Us	PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	020343-001	Aug 9, 1994		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PRIMACOR

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sanofi Aventis Us	PRIMACOR	milrinone lactate	INJECTABLE;INJECTION	019436-001	Dec 31, 1987	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PRIMACOR

See the table below for patents covering PRIMACOR around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Finland	77851		⤷ Sign Up
France	2470124	5-(PYRIDINYL)-2(1H)PYRIDINONES, LEUR PREPARATION ET LEUR UTILISATION COMME AGENTS CARDIOTONIQUES	⤷ Sign Up
Norway	854001		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for PRIMACOR

Recent Clinical Trials for PRIMACOR

Make Better Decisions: Try a trial or see plans & pricing